论文信息 - RAAS inhibitors do not increase the risk of COVID-19 - 字舞流文

RAAS inhibitors do not increase the risk of COVID-19

I. Fernández-Ruíz

[1] M. Chung,et al. Association of Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Testing Positive for Coronavirus Disease 2019 (COVID-19). , 2020, JAMA cardiology.

[2] L. Rodríguez-Mañas,et al. Use of renin–angiotensin–aldosterone system inhibitors and risk of COVID-19 requiring admission to hospital: a case-population study , 2020, The Lancet.

[3] M. Chung,et al. Association of Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Testing Positive for Coronavirus Disease 2019 (COVID-19). , 2020, JAMA cardiology.

[4] Amit N. Patel,et al. Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19 , 2020, The New England journal of medicine.

[5] G. Mancia,et al. Renin–Angiotensin–Aldosterone System Blockers and the Risk of Covid-19 , 2020, The New England journal of medicine.

[6] A. Troxel,et al. Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Covid-19 , 2020, The New England journal of medicine.